McKesson Co. (NYSE:MCK) Position Raised by Cascade Investment Advisors Inc.

Baupost Group LLC MA grew its stake in McKesson by 33.7% in the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares of the …

McKesson logoCascade Investment Advisors Inc. boosted its position in shares of McKesson Co. (NYSE:MCK) by 3.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,905 shares of the company’s stock after purchasing an additional 260 shares during the period. Cascade Investment Advisors Inc.’s holdings in McKesson were worth $763,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Nordea Investment Management AB grew its stake in McKesson by 48.8% in the 3rd quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock worth $437,856,000 after acquiring an additional 1,082,398 shares in the last quarter. Pzena Investment Management LLC grew its stake in McKesson by 11.4% in the 3rd quarter. Pzena Investment Management LLC now owns 3,160,195 shares of the company’s stock worth $419,200,000 after acquiring an additional 323,485 shares in the last quarter. Baupost Group LLC MA grew its stake in McKesson by 33.7% in the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock worth $288,607,000 after acquiring an additional 548,000 shares in the last quarter. Kiltearn Partners LLP grew its stake in McKesson by 9.1% in the 3rd quarter. Kiltearn Partners LLP now owns 2,040,651 shares of the company’s stock worth $270,692,000 after acquiring an additional 170,753 shares in the last quarter. Finally, American Century Companies Inc. grew its stake in McKesson by 13.6% in the 3rd quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock worth $230,214,000 after acquiring an additional 207,533 shares in the last quarter. Institutional investors own 91.31% of the company’s stock.

A number of brokerages have commented on MCK. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research note on Monday, February 4th. Zacks Investment Research raised shares of McKesson from a “hold” rating to a “buy” rating and set a $144.00 price target for the company in a research report on Monday, February 4th. Barclays reaffirmed a “hold” rating and issued a $130.00 price target on shares of McKesson in a research report on Friday, February 1st. Deutsche Bank raised shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 price target for the company in a research report on Friday, January 25th. Finally, UBS Group began coverage on shares of McKesson in a research report on Thursday, January 17th. They issued a “neutral” rating and a $134.00 price target for the company. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $137.99.

NYSE:MCK traded up $1.17 during midday trading on Friday, reaching $135.56. 1,072,244 shares of the stock traded hands, compared to its average volume of 1,705,008. The stock has a market capitalization of $26.00 billion, a price-to-earnings ratio of 10.74, a PEG ratio of 1.40 and a beta of 1.25. McKesson Co. has a 12-month low of $106.11 and a 12-month high of $160.87. The company has a quick ratio of 0.57, a current ratio of 1.02 and a debt-to-equity ratio of 0.81.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, January 31st. The company reported $3.40 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.18 by $0.22. The business had revenue of $56.21 billion during the quarter, compared to analysts’ expectations of $55.27 billion. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. During the same quarter last year, the company posted $3.41 earnings per share. As a group, analysts expect that McKesson Co. will post 13.55 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 1st. Shareholders of record on Friday, March 1st will be issued a $0.39 dividend. The ex-dividend date is Thursday, February 28th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.15%. McKesson’s dividend payout ratio is currently 12.36%.

In other news, EVP Lori A. Schechter sold 7,700 shares of the stock in a transaction on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total value of $946,792.00. Following the sale, the executive vice president now owns 10,000 shares in the company, valued at $1,229,600. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.87% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “McKesson Co. (NYSE:MCK) Position Raised by Cascade Investment Advisors Inc.” was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/02/17/mckesson-co-mck-holdings-lifted-by-cascade-investment-advisors-inc.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

See Also: Coverage Ratio

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for McKesson and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Weekly Duke Energy Corporation (NYSE:DUK) Ratings as of Feb 17, 2019

46 investors sold all, 386 reduced holdings as Duke Energy Corporation ratio dived. 312 increased stakes while 79 funds bought stakes. Funds hold …

Duke Energy Corporation (NYSE:DUK) Corporate Logo
During 2018 Q3 the big money sentiment decreased to 0.91. That’s change of 0.04, from 2018Q2’s 0.95. 46 investors sold all, 386 reduced holdings as Duke Energy Corporation ratio dived. 312 increased stakes while 79 funds bought stakes. Funds hold 408.54 million shares thus 94.96% less from 2018Q2’s 8.11 billion shares.

Tokio Marine Asset Mgmt Ltd owns 13,552 shs or 0.19% of their US capital. Acg Wealth accumulated 9,917 shs. King Wealth owns 2,616 shs for 0.07% of their capital. Pnc Services Gru owns 0.04% invested in Duke Energy Corporation (NYSE:DUK) for 586,673 shs. National Bank & Trust Of Montreal Can, Ontario – Canada-based fund reported 1.16M shs. Oakworth Capital stated it has 10,130 shs. Adirondack Company holds 1,203 shs or 0.06% of its capital. Jane Street Grp Ltd Company holds 0% of its capital in Duke Energy Corporation (NYSE:DUK) for 25,247 shs. 33.44M were reported by State Street Corp. Raab Moskowitz Asset Management Limited Liability Corporation, New Jersey-based fund reported 4,020 shs. Pennsylvania Communication holds 0.04% or 12,168 shs. Moreover, Pensionfund Dsm Netherlands has 0.58% invested in Duke Energy Corporation (NYSE:DUK). Old Republic Corporation holds 1.57% in Duke Energy Corporation (NYSE:DUK) or 674,131 shs. Fmr Ltd Liability Com holds 0.05% of its capital in Duke Energy Corporation (NYSE:DUK) for 5.22 million shs. Pitcairn Communication, Pennsylvania-based fund reported 2,583 shs.

Duke Energy Corporation (NYSE:DUK) Ratings Coverage

A total of 5 analysts rate Duke Energy (NYSE:DUK) as follows: 0 “Buy”, 5 “Hold” and 0 “Sell”. Тherefore 0 are bullish. (NYSE:DUK) has 8 ratings reports on Feb 17, 2019 according to StockzIntelligence. On Wednesday, January 9 the rating was downgraded by Bank of America to “Neutral”. The company rating was maintained by Wells Fargo on Monday, September 17. On Friday, February 15 the rating was downgraded by Credit Suisse to “Hold”. On Monday, November 19 the stock of Duke Energy Corporation (NYSE:DUK) earned “Equal-Weight” rating by Barclays Capital. The company rating was maintained by Morgan Stanley on Tuesday, September 11. The stock rating was maintained by Wells Fargo with “Market Perform” on Monday, November 5. On Friday, September 21 the stock has “Equal-Weight” rating by Morgan Stanley. On Tuesday, February 12 the rating was maintained by Morgan Stanley with “Equal-Weight”. Listed here are Duke Energy Corporation (NYSE:DUK) PTs and latest ratings.

15/02/2019 Broker: Credit Suisse Rating: Hold New Target: $88 Downgrade

12/02/2019 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $85 New Target: $88 Maintain

09/01/2019 Broker: Bank of America Old Rating: Buy New Rating: Neutral Old Target: $88 New Target: $87 Downgrade

19/11/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $86 New Target: $88 Maintain

05/11/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $89 New Target: $88 Maintain

21/09/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $91 New Target: $85 Maintain

17/09/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $86 New Target: $89 Maintain

11/09/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $86 New Target: $91 Maintain

DUK reached $87.51 during the last trading session after $0.31 change.Duke Energy Corporation is uptrending after having risen 2.97% since February 17, 2018. DUK has 4.47 million volume or 28.32% up from normal. DUK outperformed by 2.97% the S&P 500.

Duke Energy Corporation, together with its subsidiaries, operates as an energy firm in the United States.The company has $62.38 billion market cap. It operates through three divisions: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Commercial Renewables.23.29 is the P/E ratio. The Electric Utilities and Infrastructure segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, and the Midwest; uses coal, hydroelectric, natural gas, oil, renewable generation, and nuclear fuel to generate electricity; and engages in the wholesale of electricity to municipalities, electric cooperative utilities, and other load-serving entities.

For more Duke Energy Corporation (NYSE:DUK) news brought out briefly go to: Globenewswire.com, Seekingalpha.com, Investorplace.com, 247Wallst.com or Seekingalpha.com. The titles are as follows: “Market Trends Toward New Normal in Duke Energy, VICI Properties, MyoKardia, FLIR, TIER REIT, and ChannelAdvisor — Emerging Consolidated Expectations, Analyst Ratings – GlobeNewswire” brought out on February 04, 2019, “Duke Energy dips into the red as Q4 earnings come up short – Seeking Alpha” on February 14, 2019, “The 9 Best Stocks to Invest In During a Manic Market – Investorplace.com” with a publish date: February 06, 2019, “RBC Best Idea 2019 Utility Stocks for an Overbought and Overvalued Market – 24/7 Wall St.” and the last “Duke Energy: Wait For A Pullback – Seeking Alpha” with publication date: February 05, 2019.

Duke Energy Corporation (NYSE:DUK) Institutional Investors Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

WINTON GROUP Ltd Purchases New Position in McKesson Co. (MCK)

WINTON GROUP Ltd purchased a new position in shares of McKesson Co. (NYSE:MCK) in the fourth quarter, according to the company in its most …

McKesson logoWINTON GROUP Ltd purchased a new position in shares of McKesson Co. (NYSE:MCK) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 28,670 shares of the company’s stock, valued at approximately $3,167,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Oregon Public Employees Retirement Fund lifted its stake in McKesson by 8,651.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 8,416,267 shares of the company’s stock worth $76,000 after purchasing an additional 8,320,093 shares during the period. Nordea Investment Management AB raised its stake in shares of McKesson by 48.8% in the third quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock valued at $437,856,000 after acquiring an additional 1,082,398 shares during the last quarter. Pzena Investment Management LLC raised its stake in shares of McKesson by 11.4% in the third quarter. Pzena Investment Management LLC now owns 3,160,195 shares of the company’s stock valued at $419,200,000 after acquiring an additional 323,485 shares during the last quarter. Baupost Group LLC MA raised its stake in shares of McKesson by 33.7% in the third quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock valued at $288,607,000 after acquiring an additional 548,000 shares during the last quarter. Finally, Kiltearn Partners LLP raised its stake in shares of McKesson by 9.1% in the third quarter. Kiltearn Partners LLP now owns 2,040,651 shares of the company’s stock valued at $270,692,000 after acquiring an additional 170,753 shares during the last quarter. Hedge funds and other institutional investors own 91.31% of the company’s stock.

MCK stock opened at $135.56 on Friday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.02 and a quick ratio of 0.57. McKesson Co. has a fifty-two week low of $106.11 and a fifty-two week high of $160.87. The company has a market capitalization of $26.00 billion, a P/E ratio of 10.74, a P/E/G ratio of 1.40 and a beta of 1.25.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, January 31st. The company reported $3.40 earnings per share for the quarter, topping the consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The firm had revenue of $56.21 billion during the quarter, compared to analysts’ expectations of $55.27 billion. During the same quarter in the previous year, the company posted $3.41 EPS. As a group, sell-side analysts forecast that McKesson Co. will post 13.55 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 1st will be given a $0.39 dividend. This represents a $1.56 annualized dividend and a yield of 1.15%. The ex-dividend date is Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is presently 12.36%.

In related news, EVP Lori A. Schechter sold 7,700 shares of the business’s stock in a transaction that occurred on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total value of $946,792.00. Following the completion of the transaction, the executive vice president now owns 10,000 shares in the company, valued at approximately $1,229,600. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.87% of the company’s stock.

A number of research firms have recently issued reports on MCK. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research note on Monday, February 4th. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $144.00 target price for the company in a research note on Monday, February 4th. Barclays reiterated a “hold” rating and issued a $130.00 target price on shares of McKesson in a research note on Friday, February 1st. Deutsche Bank upgraded shares of McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price for the company in a research note on Friday, January 25th. Finally, Morgan Stanley cut their target price on shares of McKesson from $142.00 to $130.00 in a research note on Sunday, December 9th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $137.99.

WARNING: “WINTON GROUP Ltd Purchases New Position in McKesson Co. (MCK)” was first published by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/02/17/winton-group-ltd-purchases-new-position-in-mckesson-co-mck.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Recommended Story: Initial Public Offering (IPO)

Want to see what other hedge funds are holding MCK?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for McKesson and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Securian Asset Management Inc Sells 496 Shares of McKesson Co. (MCK)

Baupost Group LLC MA grew its position in shares of McKesson by 33.7% during the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares …

McKesson logoSecurian Asset Management Inc decreased its position in McKesson Co. (NYSE:MCK) by 2.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,763 shares of the company’s stock after selling 496 shares during the period. Securian Asset Management Inc’s holdings in McKesson were worth $2,183,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Nordea Investment Management AB grew its position in shares of McKesson by 48.8% during the 3rd quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock valued at $437,856,000 after acquiring an additional 1,082,398 shares during the period. Pzena Investment Management LLC grew its position in shares of McKesson by 11.4% during the 3rd quarter. Pzena Investment Management LLC now owns 3,160,195 shares of the company’s stock valued at $419,200,000 after acquiring an additional 323,485 shares during the period. Baupost Group LLC MA grew its position in shares of McKesson by 33.7% during the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock valued at $288,607,000 after acquiring an additional 548,000 shares during the period. Kiltearn Partners LLP grew its position in shares of McKesson by 9.1% during the 3rd quarter. Kiltearn Partners LLP now owns 2,040,651 shares of the company’s stock valued at $270,692,000 after acquiring an additional 170,753 shares during the period. Finally, American Century Companies Inc. grew its position in shares of McKesson by 13.6% during the 3rd quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock valued at $230,214,000 after acquiring an additional 207,533 shares during the period. Institutional investors and hedge funds own 91.31% of the company’s stock.

McKesson stock opened at $135.56 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.57 and a current ratio of 1.02. The firm has a market cap of $26.00 billion, a PE ratio of 10.74, a P/E/G ratio of 1.40 and a beta of 1.25. McKesson Co. has a fifty-two week low of $106.11 and a fifty-two week high of $160.87.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, January 31st. The company reported $3.40 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.18 by $0.22. The firm had revenue of $56.21 billion for the quarter, compared to analysts’ expectations of $55.27 billion. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. During the same quarter last year, the company posted $3.41 EPS. As a group, equities analysts forecast that McKesson Co. will post 13.55 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, April 1st. Stockholders of record on Friday, March 1st will be given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is currently 12.36%.

In related news, EVP Lori A. Schechter sold 7,700 shares of the stock in a transaction on Wednesday, January 16th. The shares were sold at an average price of $122.96, for a total transaction of $946,792.00. Following the transaction, the executive vice president now owns 10,000 shares of the company’s stock, valued at approximately $1,229,600. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.87% of the stock is currently owned by company insiders.

MCK has been the subject of a number of research reports. Royal Bank of Canada set a $155.00 target price on shares of McKesson and gave the company a “hold” rating in a research report on Friday, October 26th. Barclays dropped their price target on shares of McKesson from $150.00 to $136.00 and set an “equal weight” rating on the stock in a research note on Friday, October 26th. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research note on Monday, October 29th. Morgan Stanley dropped their price target on shares of McKesson from $142.00 to $130.00 and set an “equal weight” rating on the stock in a research note on Monday, December 3rd. Finally, Zacks Investment Research cut shares of McKesson from a “hold” rating to a “sell” rating in a research note on Thursday, January 3rd. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $137.99.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/02/17/securian-asset-management-inc-sells-496-shares-of-mckesson-co-mck.html.

McKesson Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Featured Article: Asset Allocation Models, Which is Right For You?

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for McKesson and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts

Pfizer (PFE) Shareholder Jones Collombin Investment Counsel Boosted Stake; Baupost Group …

Jones Collombin Investment Counsel Inc increased its stake in Pfizer Inc (PFE) by 11.33% based on its latest 2018Q3 regulatory filing with the SEC.

McKesson Corporation (NYSE:MCK) Logo

Jones Collombin Investment Counsel Inc increased its stake in Pfizer Inc (PFE) by 11.33% based on its latest 2018Q3 regulatory filing with the SEC. Jones Collombin Investment Counsel Inc bought 28,145 shares as the company’s stock rose 5.56% while stock markets declined. The institutional investor held 276,622 shares of the health care company at the end of 2018Q3, valued at $12.19M, up from 248,477 at the end of the previous reported quarter. Jones Collombin Investment Counsel Inc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $245.09 billion market cap company. The stock increased 1.02% or $0.43 during the last trading session, reaching $42.4. About 18.19M shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since February 17, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 24/05/2018 – The settlement announced by the U.S. Department of Justice resolves allegations that Pfizer violated the federal False Claims Act between 2012 and 2016; 29/03/2018 – PFIZER INC – STUDY MET ITS PRIMARY ENDPOINT; 01/05/2018 – PFIZER: PDL1 IS BIOMARKER WITH ‘SOLID DATA’ FOR PFS AND OS; 15/05/2018 – Rexahn Pharm: SMC Confirmed Combination of RX-3117 and Abraxane Is Safe and Well Tolerated; 19/03/2018 – Pfizer at Investor Day Hosted By H.C. Wainwright Today; 17/04/2018 – POSITIVE RESULTS WITH DIVITUM® FROM NEW PFIZER STUDY PRESENTED AT THE AACR CONGRESS; 25/05/2018 – IMFINZI(R) (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non-Small Cell Lung Cancer; 23/03/2018 – PFIZER INC – STUDY DID NOT MEET ITS PRIMARY ENDPOINT; 03/04/2018 – Pfizer in talks with P&G on sale of its consumer business, though far apart on price; 23/04/2018 – Pfizer: Additional Info Doesn’t Relate to Safety or Clinical Data Submitted in Biologics License Application

Baupost Group Llc increased its stake in Mckesson Corp (MCK) by 33.67% based on its latest 2018Q3 regulatory filing with the SEC. Baupost Group Llc bought 548,000 shares as the company’s stock declined 5.57% with the market. The hedge fund held 2.18M shares of the other pharmaceuticals company at the end of 2018Q3, valued at $288.61 million, up from 1.63 million at the end of the previous reported quarter. Baupost Group Llc who had been investing in Mckesson Corp for a number of months, seems to be bullish on the $26.00B market cap company. The stock increased 0.87% or $1.17 during the last trading session, reaching $135.56. About 1.07 million shares traded. McKesson Corporation (NYSE:MCK) has declined 17.94% since February 17, 2018 and is downtrending. It has underperformed by 17.94% the S&P500. Some Historical MCK News: 15/05/2018 – McKesson High Volume Solutions and Discount Drug Mart Partner to Build a Central Fill Pharmacy; 07/05/2018 – ROBBINS:ROBBINS SAID ADDED TO MCKESSON POSITION IN RECENT WEEKS; 24/04/2018 – McKesson and PrescribeWellness Announce Five-Year Partnership to Provide VaccineComplete and Expanded Access to Collaborative Practice Agreements; 05/04/2018 – McKesson Specialty Health Partners with CoverMyMeds to Deliver Keynote Address at eyeforpharma Philadelphia 2018; 25/04/2018 – STAT Plus: McKesson board exonerates execs from opioid crisis, but the Teamsters cry foul; 16/04/2018 – Cardinal Health and McKesson are among the companies that have been seen as vulnerable to Amazon’s entry into health care; 04/04/2018 – McKesson Specialty Health and CoverMyMeds Launch ExpressCoverage™, an Integrated eServices Platform Designed to Improve the Patient Care Journey; 25/04/2018 – McKesson: Growth Priorities Include New Offerings to Strengthen, Expand Role of Retail Pharmacy in Patient Care Delivery; 30/04/2018 – McKesson Bd of Directors Elects Brad Lerman as New Independent Director; 24/05/2018 – McKesson 4Q Loss $1.15B

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It is positive, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Shine Investment Advisory Serv Inc, a Colorado-based fund reported 5,185 shares. Patriot Wealth Mngmt holds 1.35% or 243,476 shares in its portfolio. Mastrapasqua Asset Mngmt Inc, a Tennessee-based fund reported 24,917 shares. Telemus Lc holds 0.24% in Pfizer Inc. (NYSE:PFE) or 72,129 shares. 1St Source State Bank holds 0.5% of its portfolio in Pfizer Inc. (NYSE:PFE) for 142,314 shares. Becker Management holds 1.58 million shares or 2.21% of its portfolio. Usca Ria Ltd Liability Corp reported 1.24% in Pfizer Inc. (NYSE:PFE). Salzhauer Michael invested in 0.1% or 5,988 shares. Forward Mgmt Lc accumulated 34,157 shares or 0.25% of the stock. Rmb Capital Limited stated it has 166,304 shares. Driehaus Mngmt Ltd Liability invested in 8,194 shares. Mraz Amerine Assocs Inc holds 9,968 shares. Signature Mgmt, a Virginia-based fund reported 71,026 shares. Sigma Planning, Michigan-based fund reported 141,816 shares. 493,267 are held by Clifford Swan Invest Counsel Ltd Liability Co.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus – StreetInsider.com” on January 29, 2019, also Seekingalpha.com with their article: “Pfizer Q4 2018 Earnings Preview – Seeking Alpha” published on January 28, 2019, Seekingalpha.com published: “Pfizer: Strong Buy Heading Into 2019 – Seeking Alpha” on January 30, 2019. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC – StreetInsider.com” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “Pfizer: Still A Cash Cow – Seeking Alpha” with publication date: January 22, 2019.

Jones Collombin Investment Counsel Inc, which manages about $290.33M US Long portfolio, decreased its stake in At&T Inc (NYSE:T) by 80,451 shares to 16,717 shares, valued at $561,000 in 2018Q3, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 22,882 shares in the quarter, leaving it with 32,389 shares, and cut its stake in General Dynamics Corp (NYSE:GD).

Since January 30, 2019, it had 0 insider buys, and 1 insider sale for $1.81 million activity.

Among 23 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Pfizer had 92 analyst reports since July 29, 2015 according to SRatingsIntel. BMO Capital Markets downgraded the stock to “Market Perform” rating in Thursday, November 1 report. As per Thursday, April 7, the company rating was maintained by Jefferies. The rating was maintained by Jefferies with “Hold” on Wednesday, August 16. SunTrust maintained the shares of PFE in report on Monday, October 16 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Monday, July 10 by Cowen & Co. On Wednesday, November 2 the stock rating was downgraded by Argus Research to “Hold”. The firm earned “Overweight” rating on Thursday, August 23 by Morgan Stanley. The rating was maintained by UBS with “Buy” on Wednesday, November 1. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Monday, October 16 by Jefferies. The company was downgraded on Tuesday, December 11 by JP Morgan.

Among 22 analysts covering McKesson Corporation (NYSE:MCK), 11 have Buy rating, 1 Sell and 10 Hold. Therefore 50% are positive. McKesson Corporation had 92 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by Raymond James to “Mkt Perform” on Tuesday, January 12. The stock has “Mkt Perform” rating by Leerink Swann on Friday, October 28. The stock of McKesson Corporation (NYSE:MCK) has “Hold” rating given on Tuesday, April 4 by Needham. The company was maintained on Tuesday, August 29 by Jefferies. The stock of McKesson Corporation (NYSE:MCK) has “Equal-Weight” rating given on Tuesday, July 3 by Morgan Stanley. The firm has “Hold” rating given on Tuesday, April 26 by Standpoint Research. The stock has “Hold” rating by Mizuho on Wednesday, January 24. The firm has “Buy” rating by Standpoint Research given on Tuesday, July 10. On Monday, September 26 the stock rating was maintained by Mizuho with “Neutral”. As per Friday, October 28, the company rating was upgraded by Standpoint Research.

More notable recent McKesson Corporation (NYSE:MCK) news were published by: Seekingalpha.com which released: “FDA warns McKesson over opioid supply chain – Seeking Alpha” on February 12, 2019, also Seekingalpha.com with their article: “McKesson Q3 2018 Earnings Preview – Seeking Alpha” published on January 30, 2019, Seekingalpha.com published: “McKesson FQ3 sales up 5% – Seeking Alpha” on January 31, 2019. More interesting news about McKesson Corporation (NYSE:MCK) were released by: Seekingalpha.com and their article: “McKesson: Homing In On A Bottom – Seeking Alpha” published on December 17, 2018 as well as Seekingalpha.com‘s news article titled: “McKesson Corporation 2019 Q3 – Results – Earnings Call Slides – Seeking Alpha” with publication date: January 31, 2019.

Baupost Group Llc, which manages about $29.88B and $13.01B US Long portfolio, decreased its stake in Cardinal Health Inc (NYSE:CAH) by 361,515 shares to 4.74M shares, valued at $255.88M in 2018Q3, according to the filing.

Investors sentiment decreased to 0.71 in 2018 Q3. Its down 0.34, from 1.05 in 2018Q2. It dropped, as 59 investors sold MCK shares while 296 reduced holdings. 76 funds opened positions while 176 raised stakes. 162.62 million shares or 5.64% less from 172.34 million shares in 2018Q2 were reported. Apg Asset Management Nv invested 0.01% of its portfolio in McKesson Corporation (NYSE:MCK). Country Tru National Bank reported 7 shares. Bridgeway Management Inc stated it has 363,250 shares. 165,981 were reported by Chevy Chase Trust Hldg Inc. Culbertson A N & holds 34,175 shares or 1.24% of its portfolio. 242 were reported by Motco. Peapack Gladstone Fin Corp invested in 0.07% or 10,248 shares. First Personal reported 0.14% in McKesson Corporation (NYSE:MCK). Alliancebernstein Ltd Partnership holds 924,445 shares or 0.08% of its portfolio. 2.04 million are owned by Kiltearn Prns Llp. Moreover, Meeder Asset Mngmt has 0.01% invested in McKesson Corporation (NYSE:MCK). Personal Cap Advsr holds 0% or 1,635 shares in its portfolio. Gsa Capital Llp invested in 0.08% or 10,995 shares. Da Davidson accumulated 0% or 1,531 shares. Sterling Cap Ltd Liability Corp has invested 0.52% of its portfolio in McKesson Corporation (NYSE:MCK).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts